Clinical Trials Browser

Phase 2 × Familial ependymoma × Sunitinib × Clear all

NCT01462695 2015-08-27

Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma

Phase 2 Completed

30 enrolled 8 charts

Familial ependymoma, Astrocytoma, Oligodendroglioma